Multiple sclerosis relapse during pregnancy: who is at risk?


Treatment type may predict the risk of relapse during pregnancy in women with relapsing-remitting multiple sclerosis (RRMS), researchers say.

Historically, RRMS disease activity has been known to decrease during pregnancy. However, the interaction between disease activity and pregnancy in the era of modern therapy, including high-efficacy disease-modifying therapy (DMT), is unclear.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.